Follow
Otto Metzger Filho
Otto Metzger Filho
Dana-Farber Cancer Institute
Verified email at dfci.harvard.edu
Title
Cited by
Cited by
Year
CDK4/6 inhibition triggers anti-tumour immunity
S Goel, MJ DeCristo, AC Watt, H BrinJones, J Sceneay, BB Li, N Khan, ...
Nature 548 (7668), 471-475, 2017
11582017
Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised …
S Loibl, J O'Shaughnessy, M Untch, WM Sikov, HS Rugo, MD McKee, ...
The lancet oncology 19 (4), 497-509, 2018
6742018
Dissecting the heterogeneity of triple-negative breast cancer
O Metzger-Filho, A Tutt, E De Azambuja, KS Saini, G Viale, S Loi, ...
Journal of clinical oncology 30 (15), 1879-1887, 2012
5122012
Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer
KS Saini, S Loi, E de Azambuja, O Metzger-Filho, ML Saini, M Ignatiadis, ...
Cancer treatment reviews 39 (8), 935-946, 2013
4072013
Patterns of recurrence and outcome according to breast cancer subtypes in lymph node–negative disease: results from International Breast Cancer Study Group Trials VIII and IX
O Metzger-Filho, Z Sun, G Viale, KN Price, D Crivellari, RD Snyder, ...
Journal of clinical oncology 31 (25), 3083, 2013
4062013
Genomic characterization of primary invasive lobular breast cancer
C Desmedt, G Zoppoli, G Gundem, G Pruneri, D Larsimont, M Fornili, ...
Journal of clinical oncology 34 (16), 1872-1881, 2016
2982016
Trastuzumab-associated cardiac events at 8 years of median follow-up in the Herceptin Adjuvant trial (BIG 1-01).
E De Azambuja, MJ Procter, DJ Van Veldhuisen, D Agbor-Tarh, ...
Journal of clinical oncology: official journal of the American Society of …, 2014
2582014
Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries
KS Saini, C Taylor, AJ Ramirez, C Palmieri, U Gunnarsson, HJ Schmoll, ...
Annals of oncology 23 (4), 853-859, 2012
2452012
DNA methylation profiling reveals a predominant immune component in breast cancers
S Dedeurwaerder, C Desmedt, E Calonne, SK Singhal, B Haibe‐Kains, ...
EMBO molecular medicine, 2011
2362011
CNS relapses in patients with HER2-positive early breast cancer who have and have not received adjuvant trastuzumab: a retrospective substudy of the HERA trial (BIG 1-01)
BC Pestalozzi, E Holmes, E de Azambuja, O Metzger-Filho, L Hogge, ...
The lancet oncology 14 (3), 244-248, 2013
2232013
Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study
EL Mayer, AC Dueck, M Martin, G Rubovszky, HJ Burstein, ...
The lancet oncology 22 (2), 212-222, 2021
2222021
The natural history of hormone receptor-positive breast cancer
MD Elgene Lim, O Metzger-Filho, EP Winer
Oncology 26 (8), 688, 2012
1872012
Relative effectiveness of letrozole compared with tamoxifen for patients with lobular carcinoma in the BIG 1-98 trial
O Metzger Filho, A Giobbie-Hurder, E Mallon, B Gusterson, G Viale, ...
Journal of Clinical Oncology 33 (25), 2772, 2015
1692015
Differences between invasive lobular and invasive ductal carcinoma of the breast: results and therapeutic implications
R Barroso-Sousa, O Metzger-Filho
Therapeutic advances in medical oncology 8 (4), 261-266, 2016
1412016
Bevacizumab and breast cancer: a meta-analysis of first-line phase III studies and a critical reappraisal of available evidence
JR Rossari, O Metzger-Filho, M Paesmans, KS Saini, A Gennari, ...
Journal of oncology 2012, 2012
1232012
Long-term efficacy and safety of addition of carboplatin with or without veliparib to standard neoadjuvant chemotherapy in triple-negative breast cancer: 4-year follow-up data …
CE Geyer, WM Sikov, J Huober, HS Rugo, N Wolmark, J O’Shaughnessy, ...
Annals of Oncology 33 (4), 384-394, 2022
1162022
Impact of HER2 heterogeneity on treatment response of early-stage HER2-positive breast cancer: phase II neoadjuvant clinical trial of T-DM1 combined with pertuzumab
OM Filho, G Viale, S Stein, L Trippa, DA Yardley, IA Mayer, VG Abramson, ...
Cancer discovery 11 (10), 2474-2487, 2021
1092021
Adjuvant palbociclib for early breast cancer: the PALLAS trial results (ABCSG-42/AFT-05/BIG-14-03)
M Gnant, AC Dueck, S Frantal, M Martin, HJ Burstein, R Greil, P Fox, ...
Journal of Clinical Oncology 40 (3), 282, 2022
1082022
Breast conservation after neoadjuvant chemotherapy for triple-negative breast cancer: surgical results from the BrighTNess randomized clinical trial
M Golshan, S Loibl, SM Wong, JB Huober, J O’Shaughnessy, HS Rugo, ...
JAMA surgery 155 (3), e195410-e195410, 2020
992020
SnapShot: breast cancer
K Polyak, O Metzger Filho
Cancer cell 22 (4), 562-562. e1, 2012
952012
The system can't perform the operation now. Try again later.
Articles 1–20